Targeted disruption of mouse ortholog of the human MYH9 responsible for macrothrombocytopenia with different organ involvement: hematological, nephrological …

T Matsushita, H Hayashi, S Kunishima… - Biochemical and …, 2004 - Elsevier
T Matsushita, H Hayashi, S Kunishima, M Hayashi, M Ikejiri, K Takeshita, Y Yuzawa…
Biochemical and biophysical research communications, 2004Elsevier
Among three different isoforms of non-muscle myosin heavy chains (NMMHCs), only
NMMHCA is associated with inherited human disease, called MYH9 disorders,
characterized by macrothrombocytopenia and characteristic granulocyte inclusions. Here
targeted gene disruption was performed to understand fundamental as well as pathological
role of the gene for NMMHCA, MYH9. Heterozygous intercrosses yielded no homozygous
animals among 552 births, suggesting that MYH9 expression is required for embryonic …
Among three different isoforms of non-muscle myosin heavy chains (NMMHCs), only NMMHCA is associated with inherited human disease, called MYH9 disorders, characterized by macrothrombocytopenia and characteristic granulocyte inclusions. Here targeted gene disruption was performed to understand fundamental as well as pathological role of the gene for NMMHCA, MYH9. Heterozygous intercrosses yielded no homozygous animals among 552 births, suggesting that MYH9 expression is required for embryonic development. In contrast, MYH9+/− mice were viable and fertile without gross anatomical, hematological, and nephrological abnormalities. Immunofluorescence analysis also showed the normal cytoplasmic distribution of NMMHCA. We further measured the auditory brainstem response and found two of six MYH9+/− mice had hearing losses, whereas the remaining four were comparable to wild-type mice. Such observation may parallel the diverse expression of Alport’s manifestations of human individuals with MYH9 disorders and suggest the limited requirement of the gene for maintenance and function of specific organs.
Elsevier